Healthcare / Medical Care FacilitiesJohannesburg
$100.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $123.3M · quality 51.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
14/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$819M
P/E
N/A
•EV/EBITDA
N/A
•ROE
N/A
•Gross Margin
58.1%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
3.5%
FCF / Net income
-10.24x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.50B · net income $-28.8M · FCF $294.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.50B | $8.50B | $3.77B | $8.76B | — |
| Net Income | $-28.8M | $-28.8M | $-125.9M | $183.5M | — |
| EBITDA | $577.8M | $577.8M | $457.0M | $878.8M | — |
| EPS | — | — | -0.15 | 0.30 | 0.53 |
| Gross Margin | 58.1% | 58.1% | 62.6% | 54.6% | — |
| Operating Margin | 7.9% | 7.9% | 3.6% | 17.6% | — |
| Net Margin | -0.3% | -0.3% | -3.3% | 2.1% | — |
| Balance Sheet | |||||
| Debt/Equity | — | — | 0.24 | 0.29 | 0.35 |
| Cash Flow | |||||
| Free Cash Flow | $294.9M | $294.9M | $114.3M | $123.3M | — |
| Returns | |||||
| ROE | — | — | -3.9% | 5.3% | — |
| Valuation | |||||
| P/E | — | — | — | 1369.63 | 851.27 |
| EV/EBITDA | — | — | 568.09 | 286.95 | — |
| P/B | — | — | 79.85 | 73.00 | 109.21 |
| Growth & Yield | |||||
| Revenue Growth | 125.8% | 125.8% | -57.0% | — | — |
| EPS Growth | — | — | -150.6% | -43.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-32.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.15 → n/d
Residual
-32.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.